Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides
Open Access
- 1 July 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-13
Abstract
Accurate risk stratification is critical for guiding treatment decisions in early breast cancer. We present an artificial intelligence (AI)-based tool that analyzes digitized tumor slides to predict 5-year metastasis-free survival (MFS) in patients with estrogen receptor-positive, HER2-negative (ER + /HER2 − ) early breast cancer (EBC). Our deep learning model, RlapsRisk BC, independently predicts MFS and provides significant prognostic value beyond traditional clinico-pathological variables (C-index 0.81 vs 0.76, p < 0.05). Applying a 5% MFS event probability threshold stratifies patients into low- and high-risk groups. After dichotomization, combining RlapsRisk BC with clinico-pathological factors increases cumulative sensitivity (0.69 vs 0.63) and dynamic specificity (0.80 vs 0.76) compared to clinical factors alone. Expert analysis of high-impact regions identified by the model highlights well-established morphological features, supporting its interpretability and biological relevance.Keywords
All Related Versions
This publication has 54 references indexed in Scilit:
- Improved breast cancer histological grading using deep learningAnnals of Oncology, 2022
- Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE studyAnnals of Oncology, 2021
- Mise à jour 2021 des recommandations du GEFPICS pour l’évaluation du statut HER2 dans les cancers infiltrants du sein en FranceAnnales de Pathologie, 2021
- HER2 immunohistochemistry inter-observer reproducibility in 205 cases of invasive breast carcinoma additionally tested by ISHAnnals of Diagnostic Pathology, 2020
- Artificial intelligence in digital breast pathology: Techniques and applicationsThe Breast, 2020
- Comparison of the Performance of 6 Prognostic Signatures for Estrogen Receptor–Positive Breast CancerJAMA Oncology, 2018
- Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreementBreast Cancer Research and Treatment, 2018
- The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinicEuropean Journal of Cancer, 2016
- U-Net: Convolutional Networks for Biomedical Image Segmentation2015
- A population-based validation of the prognostic model PREDICT for early breast cancerEuropean Journal of Surgical Oncology, 2011